Livingston, United Kingdom, 22 February 2010

Encap Drug Delivery is pleased to announce that it has formed a working partnership with Alfa Chemicals who will represent Encap Drug Delivery in the UK and Ireland, promoting Encap's services alongside Gattefossé's range of advanced lipid excipients.

The partnership with Encap drug delivery provides a synergy between Gattefossé's expertise in the development of advanced lipid excipients and formulations for enhancing bioavailability and Encap's expertise in the formulation development and manufacture of hard capsules with liquids or semi-solids. Together we can help customers move more quickly from concept to commercial manufacture.

Comments from Mark Walker, Managing Director of Alfa Chemicals and Gattefossé UK:

The partnership with Encap will enable us to pool the expertise and experience that Alfa Chemicals has gained during almost 20 years of promoting excipients in the UK , and during our joint venture with Gattefossé s.a in France, with the market leading skills and knowledge of Encap to the benefit of our mutual clients.

Comments from Dr. Stephen Brown, Chief Operating Officer of Encap Drug Delivery:

Encap is delighted to enter into a strategic  alliance with Alfa Chemical (UK & Ireland). This  alliance will bring synergy to the formulation bench for customers trying to  enhance the bioavailability of poorly soluble compounds, which seem to be prevalent in the Pharmaceutical industry. Alfa Chemicals promote excipients to facilitate enhancing bioavailability. Encap, has over 20 years experience in dedicated formulation expertise in this area. Together, we can help the customer move quickly from concept to commercial manufacture. By forming this alliance, clients will benefit from the expertise of two leaders in oral drug delivery services.